ImmunoCellular, University of Texas M.D. Anderson Cancer Center deal

The university granted ImmunoCellular an option to license exclusive, worldwide rights to an immunotherapy targeting cancer stem cells. The immunotherapy uses abnormal Notch and Numb peptides and is i...